Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)
 
 • Company Description   
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

Number of Employees: 4,434

 
 • Price / Volume Information   
Yesterday's Closing Price: $235.54 Daily Weekly Monthly
20 Day Moving Average: 1,159,376 shares
Shares Outstanding: 138.32 (millions)
Market Capitalization: $32,580.16 (millions)
Beta: 1.63
52 Week High: $246.90
52 Week Low: $125.38
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.67% -2.38%
12 Week 45.75% 41.10%
Year To Date 48.79% 26.25%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13011 McCallen Pass Building A Suite 100
-
Austin,TX 78753
USA		 ph: 650-980-9190
fax: -		 investor@natera.com http://www.natera.com
 
 • General Corporate Information   
Officers
Steve Chapman - Chief Executive Officer and President
Matthew Rabinowitz - Executive Chairman
Michael Brophy - Chief Financial Officer
Roy Baynes - Director
Roelof F. Botha - Director

Peer Information
Natera, Inc. (CHCR)
Natera, Inc. (ESRX)
Natera, Inc. (MYDP)
Natera, Inc. (COR)
Natera, Inc. (GBCS)
Natera, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 632307104
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/26/26
Share - Related Items
Shares Outstanding: 138.32
Most Recent Split Date: (:1)
Beta: 1.63
Market Capitalization: $32,580.16 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.50 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.38 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/26/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 25.82
Price/Cash Flow: -
Price / Sales: 15.39
EPS Growth
vs. Year Ago Period: -146.15%
vs. Previous Quarter: 13.51%
Sales Growth
vs. Year Ago Period: 34.66%
vs. Previous Quarter: 8.34%
ROE
09/30/25 - -25.07
06/30/25 - -22.22
03/31/25 - -18.29
ROA
09/30/25 - -17.74
06/30/25 - -15.03
03/31/25 - -11.68
Current Ratio
09/30/25 - 3.27
06/30/25 - 3.72
03/31/25 - 3.87
Quick Ratio
09/30/25 - 3.13
06/30/25 - 3.58
03/31/25 - 3.74
Operating Margin
09/30/25 - -14.61
06/30/25 - -12.89
03/31/25 - -10.36
Net Margin
09/30/25 - -14.61
06/30/25 - -12.89
03/31/25 - -10.36
Pre-Tax Margin
09/30/25 - -14.64
06/30/25 - -12.90
03/31/25 - -10.34
Book Value
09/30/25 - 9.12
06/30/25 - 9.13
03/31/25 - 9.17
Inventory Turnover
09/30/25 - 14.38
06/30/25 - 14.73
03/31/25 - 15.14
Debt-to-Equity
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©